Champions Oncology, Inc. (CSBR) is a publicly traded Healthcare sector company. As of May 21, 2026, CSBR trades at $5.99 with a market cap of $84.29M and a P/E ratio of 17.65. CSBR moved +0.00% today. Year to date, CSBR is -9.16%; over the trailing twelve months it is +2.20%. Its 52-week range spans $3.75 to $11.99. Rallies surfaces CSBR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading CSBR stock inside the company?
Recent CSBR insider activity includes Mendelson Daniel Newman bought 1.00K, Mendelson Daniel Newman bought 2.00K, Mendelson Daniel Newman bought 2.94K, Mendelson Daniel Newman bought 3.00K, and Mendelson Daniel Newman bought 1.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
CSBR Key Metrics
Key financial metrics for CSBR
Metric
Value
Price
$5.99
Market Cap
$84.29M
P/E Ratio
17.65
EPS
$0.34
Dividend Yield
0.00%
52-Week High
$11.99
52-Week Low
$3.75
Volume
0
Avg Volume
0
Revenue (TTM)
$56.94M
Net Income
$4.70M
Gross Margin
50.15%
Recent CSBR Insider Trades
Mendelson Daniel Newman bought 1.00K (~$6.50K) on Jan 12, 2024.
Mendelson Daniel Newman bought 2.00K (~$12.54K) on Jan 11, 2024.
Mendelson Daniel Newman bought 2.94K (~$18.58K) on Jan 10, 2024.
Mendelson Daniel Newman bought 3.00K (~$18.75K) on Jan 9, 2024.
Mendelson Daniel Newman bought 1.00K (~$6.15K) on Jan 8, 2024.
CSBR analyst coverage data. Average price target: $0.00.
Common questions about CSBR
Who is trading CSBR stock inside the company?
Recent CSBR insider activity includes Mendelson Daniel Newman bought 1.00K, Mendelson Daniel Newman bought 2.00K, Mendelson Daniel Newman bought 2.94K, Mendelson Daniel Newman bought 3.00K, and Mendelson Daniel Newman bought 1.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CSBR?
Yes. Rallies tracks CSBR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CSBR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CSBR. It does not provide personalized investment advice.